http://rdf.ncbi.nlm.nih.gov/pubchem/reference/5264756

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't|Research Support, U.S. Gov't, Non-P.H.S.
endingPage 1280
issn 1557-3265
1078-0432
issueIdentifier 6
pageRange 1273-1280
publicationName Clinical cancer research : an official journal of the American Association for Cancer Research
startingPage 1273
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_aa0ab95f6bdd42487dc29cd9ea2a95e4
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ab80a732b5df33e85751c0a758afb577
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_d62f51386142d8e7576b9b70134d6e59
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_5e4651ddb1e2085b46c23e16f1148a9b
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_bd32df969a65cc2e223fdc4e7f84d332
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_4c4f4a6c5972ec75e3fd979c7098e660
bibliographicCitation Chen EJ, Sowalsky AG, Gao S, Cai C, Voznesensky O, Schaefer R, Loda M, True LD, Ye H, Troncoso P, Lis RL, Kantoff PW, Montgomery RB, Nelson PS, Bubley GJ, Balk SP, Taplin ME. Abiraterone treatment in castration-resistant prostate cancer selects for progesterone responsive mutant androgen receptors. Clin Cancer Res. 2015 Mar 15;21(6):1273–80. PMID: 25320358; PMCID: PMC4359958.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_953cd3d852624df01e57dd89a13e6ab6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ae772591149be67bdedeedcaf3b0551a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d08bf03834d16555394b5f04e90c569f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8449de57daebbd4ba66bdb8f93baf1b3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0cd61cf5528ebe5b7a352bb8241b1c10
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_18780d394f57144e4c51793bbf70f82d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4d803c5374369c9f91d29e7d2278999e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a95bb23d6042156a2bac17229b629808
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dbae2aebb832719240406a4728401800
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b5f85d801dcf389a6acae1e1fc4af2c6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aa6f0e67d8726ab96929dc05369f2ecb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-7304-8801
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0af11f3dc7a3b14d48e06372af05e759
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_47ab498bbddca617faa96295693e06a3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7b8aa751669a70913d8744deb7d7d4a2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ac8fd2118addd2d87b6c9980da7431c2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3088dac1a696393e5241fffc765b9b9a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7ed4300b199ad1e39d3337b2a76cd498
date 2015-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1158/1078-0432.ccr-14-1220
https://pubmed.ncbi.nlm.nih.gov/PMC4359958
https://pubmed.ncbi.nlm.nih.gov/25320358
isPartOf https://portal.issn.org/resource/ISSN/1078-0432
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8794
https://portal.issn.org/resource/ISSN/1557-3265
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Abiraterone Treatment in Castration-Resistant Prostate Cancer Selects for Progesterone Responsive Mutant Androgen Receptors
discusses http://id.nlm.nih.gov/mesh/M0282104
http://id.nlm.nih.gov/mesh/M0281571
http://id.nlm.nih.gov/mesh/M0011987
http://id.nlm.nih.gov/mesh/M0006674
http://id.nlm.nih.gov/mesh/M0214728
http://id.nlm.nih.gov/mesh/M0006678
http://id.nlm.nih.gov/mesh/M0018556
http://id.nlm.nih.gov/mesh/M0017672
http://id.nlm.nih.gov/mesh/M0001114
http://id.nlm.nih.gov/mesh/M0025473
http://id.nlm.nih.gov/mesh/M0020523
http://id.nlm.nih.gov/mesh/M0479128
http://id.nlm.nih.gov/mesh/M0237229
http://id.nlm.nih.gov/mesh/M0486771
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D064129Q000188
http://id.nlm.nih.gov/mesh/D011944Q000235
http://id.nlm.nih.gov/mesh/D011374Q000378
http://id.nlm.nih.gov/mesh/D000736Q000627
http://id.nlm.nih.gov/mesh/D013254Q000037
hasSubjectTerm http://id.nlm.nih.gov/mesh/D009154Q000235
http://id.nlm.nih.gov/mesh/D004265Q000235
http://id.nlm.nih.gov/mesh/D007654Q000627
http://id.nlm.nih.gov/mesh/D011944Q000378
http://id.nlm.nih.gov/mesh/D051059Q000235
http://id.nlm.nih.gov/mesh/D045744
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D000369
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D000971Q000627
http://id.nlm.nih.gov/mesh/D004268Q000235
http://id.nlm.nih.gov/mesh/D019008Q000235
http://id.nlm.nih.gov/mesh/D016729Q000627
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D064129Q000235
http://id.nlm.nih.gov/mesh/D000068538Q000627
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5995
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5994
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73951506
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5702077
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10251
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3397
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID657181
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918296
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID132971
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_005ef34c8ba989d84eb20cdc3a19dd7c
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8da8a5ea353ebccee6521d648ced2fe1
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_bcd6f21312d21a5cf3f0a82f59d9ac97
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID456201
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID47576
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3823

Total number of triples: 99.